Risk Level: MediumSubQ Inject
Retatrutide
Triple GLP-1/GIP/Glucagon Receptor Agonist & Visceral Lipid Thermogenesis Engine
Aliases / Trademarks: LY3437943 · GGG Tri-agonist
Eli Lilly's first-in-class triple incretin/glucagon receptor agonist. While suppressing appetite, it uniquely engages glucagon receptors to accelerate hepatic lipid oxidation and elevate resting metabolic expenditure, achieving up to 24.2% mean clinical weight reduction.
Associated Protocol Category: View Protocol Roadmap
⏱️ Real-World Expectation & Sentiment Timeline
Week 1 - 4 (2mg Induction)：Metabolic Activation & Heart Rate Adaptation Core Milestones
Basal body temperature mildly increases by 0.2-0.3°C; mild appetite reduction
Resting heart rate may temporarily increase by 3-6 bpm
Stage Critical Guidance:Strictly adhere to 2mg weekly for the first 4 weeks to allow cardiac and metabolic tolerance to establish.
Standard Dosage & Administration Guidelines
Typical Dose
2.0mg - 12.0mg / week
Frequency
Once weekly SubQ injection (outer thigh preferred)
Cycle Length
16 - 24 weeks per protocol
Clinical & Community Notes: The most powerful fat loss kinetics in history, but resting heart rate (RHR) monitoring is essential. Outer thigh administration also smooths early gastrointestinal adaptation.
Titration Schedule & Dosing Decision Tree
Step-up ProtocolStarting & Maintenance Criteria:2.0mg once weekly for 4 full weeks
4.0mg - 8.0mg weekly is sufficient for exceptional, steady fat loss
Titration & Adjustment Rules:Step up to 4.0mg only after completing 4 full weeks; evaluate resting heart rate at each 4-week increment
| Timeline | Dosage & Frequency | Objective | Key Biomarkers / Checks |
|---|---|---|---|
| Weeks 1 - 4 | 2.0mg once weekly | Establish cardiac and metabolic tolerance; initiate thermogenic baseline | Resting heart rate (RHR), basal body temperature |
| Weeks 5 - 8 | 4.0mg once weekly | Enter deep fat-burning window; accelerate visceral and hepatic lipid mobilization | Waist circumference, liver function enzymes |
Recommended Bloodwork & Lab Biomarkers
1. Pre-Cycle Baseline Tests:
- Resting 12-Lead ECG
- Comprehensive Liver Panel (ALT/AST for fatty liver baseline)
- Lipid Panel & HOMA-IR
2. Mid & Post-Cycle Follow-Up:
- Track resting heart rate and blood pressure weekly
🚨 Critical Safety Thresholds: Reduce dosage immediately if resting heart rate remains sustained >100 bpm with palpitations or chest discomfort
Educational Composite Scenarios
1 Composite Archetypesℹ️ Names, timelines, doses, lab values, and outcomes are illustrative composites. They are not actual patient records or treatment recommendations.
14-Week Triple Agonist Journal: Breaking a 6-Month GLP-1 Weight Loss Plateau
👤 Composite Profile: Male, 40yo, stalled at 88kg for 6 months despite max-dose Semaglutide; high visceral fat rating (Grade 14).
Illustrative Protocol: Retatrutide (titrated 2mg -> 4mg -> 6mg/wk), combined with daily 8,000 brisk steps and resting HR tracking.
Illustrative Timeline:
Week 288.2kg -> 86.5kg (-1.7kg)
Weight dropped by 1.7kg within 2 weeks at 2mg; noticeable thermogenesis and energy expenditure.
Week 886.5kg -> 79.8kg (-6.7kg)
Glucagon receptor activation at 4mg accelerated abdominal waist reduction; hepatic ultrasound cleared.
Week 1479.8kg -> 74.6kg (-5.2kg)
Achieved target weight of 74.6kg with resting HR stable at 72-74 bpm.
Scenario Outcome and Learning Points: Broke a 6-month GLP-1 plateau, shedding 13.6kg with a 50% drop in visceral fat via Retatrutide triple agonism.
💡 Educational Takeaway: Retatrutide glucagon agonism uniquely drives direct hepatic lipid oxidation. Monitor resting HR during titration and limit concurrent high caffeine.
⚠️ Side Effect Mitigations & Community Hacks
Visual Syringe Reconstitution Calculator
Accurately calculate vial reconstitution concentration and U-100 syringe units
Syringe:
Quick Clinical & Community Presets:
mg
ml
mcg
Syringe Pull To Mark
40Units (Ticks on Syringe)
Equal to 0.400 ml fluid | Yields 5 doses
Conc: 5.00 mg/ml
💉 Visual Needle Simulation (U-100 Standard)Target: 40 / 100 U
① Dissolution Technique: Slowly slide BAC water down the vial wall. Never shake vigorously to protect peptide chains.
② Cold-Chain Storage: Store reconstituted liquid at 2-8°C away from light. Best used within 28-30 days.
③ Standard Syringe: Calculation based on U-100 insulin syringes (100 units = 1.0 ml).
Evidence-Based FAQs & Reddit Theoretical Mythbusters
Verified biochemical mechanisms, category physiology, and Reddit misconception clarity
1. Compound-Specific Dilemmas & Solutions
🔗 Synergistic Stacking Protocols (Synergies)
Synergy Stack
+ BPC-157
Protects gastric mucosal lining and cardiovascular endothelial homeostasis.
📊 Educational Composite Scenarios (1)
Illustrative 6-16 week timelines, sample biomarker metrics, and educational protocol takeaways for Retatrutide.
ℹ️ Names, timelines, doses, lab values, and outcomes are illustrative composites. They are not actual patient records or treatment recommendations.
Plateau BreakerMale, 40 y/o•14 Weeks Protocol
14-Week Triple Agonist Journal: Breaking a 6-Month GLP-1 Weight Loss Plateau
Illustrative Protocol: Retatrutide (titrated 2mg -> 4mg -> 6mg/wk), combined with daily 8,000 brisk steps and resting HR tracking.
Final Weight
74.6 kg
-13.6 kg (Plateau Broken)
Visceral Fat Grade
7 ()
-50% (Hepatic Fat Cleared)
Resting HR Shift
73 bpm
+5 bpm (Well-Tolerated)
Illustrative Weekly Highlights:
Week 2Weight dropped by 1.7kg within 2 weeks at 2mg; noticeable thermogenesis and energy expenditure.
Week 8Glucagon receptor activation at 4mg accelerated abdominal waist reduction; hepatic ultrasound cleared.
Week 14Achieved target weight of 74.6kg with resting HR stable at 72-74 bpm.
💡 Educational Takeaway: Retatrutide glucagon agonism uniquely drives direct hepatic lipid oxidation. Monitor resting HR during titration and limit concurrent high caffeine.
Inspect Full Scenario Dossier →Dedicated Dose & Syringe Calculator
💉 Retatrutide Reconstitution & Syringe Tick Tool
Standard vial size: 10mg. Recommended BAC water: 2ml. Typical dose: 2.0mg - 12.0mg / week.
Visual Syringe Reconstitution Calculator
Accurately calculate vial reconstitution concentration and U-100 syringe units
Syringe:
Quick Clinical & Community Presets:
mg
ml
mcg
Syringe Pull To Mark
10Units (Ticks on Syringe)
Equal to 0.100 ml fluid | Yields 20 doses
Conc: 2.50 mg/ml
💉 Visual Needle Simulation (U-100 Standard)Target: 10 / 100 U
① Dissolution Technique: Slowly slide BAC water down the vial wall. Never shake vigorously to protect peptide chains.
② Cold-Chain Storage: Store reconstituted liquid at 2-8°C away from light. Best used within 28-30 days.
③ Standard Syringe: Calculation based on U-100 insulin syringes (100 units = 1.0 ml).
Evidence Context and Common Questions
Retatrutide Key TakeawaysResearch References
References may include preclinical or clinical research and do not establish safety, efficacy, or dosing for an individual.
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine (NEJM) · 2023